Meridian Bioscience, Inc.: Magellan Diagnostics, Inc. Expands Voluntary Recall of LeadCare Test Kits
Customers should discontinue use of all LeadCare Test Kits lots identified as part of the recall and quarantine remaining inventory. Distributors should stop distribution of all LeadCare Test Kits ...
CINCINNATI, Feb. 16, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that ...
Vial for blood test The FDA is concerned that obtaining falsely low test results may lead to inappropriate follow-up assessments, which may result in patient harm. Magellan Diagnostics is recalling ...
Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced its wholly owned subsidiary, Magellan Diagnostics, Inc. (“Magellan” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results